Eucerin Dermopure Triple Effect Body Cream, 200Ml

Name: Eucerin Dermopure Triple Effect Body Cream, 200Ml
Brand: EUCERIN
SKU: EU4006000077727
Price: 17.4 EUR
Availability: InStock

eucerin

This body care treatment is dermatologist recommended and clinically proven to deliver 48 hours1 of hydration and correct blemishes and post-acne spots in 2 weeks, with a potent combination of Salicylic Acid and patented Thiamidol. 1measurement on 27 volunteers 48 hours after a single application compared to baseline.

SKU: EU4006000077727

-25%

20% discount.

€17.40

€23.30

1

Pharmaceutical Care

Safe medication sales

Secure shipping

PHARMACEUTICAL RECOMMENDATION

License Number: 7270

Silvia Del Río

A pharmacist specializing in dermocosmetics, skin microbiota, and hygiene will advise and help you with the most suitable treatment.

Ask me

eucerin

Eucerin Pack Dermopure Triple Action Serum 40Ml + Corrective Cleansing Gel 75Ml

€16.50

eucerin

Eucerin Dermopure Mattifying Moisturising Face Fluid, 50 ml

€14.60

heliocare

Heliocare Pack 360 Gel Of Spf50 + Minitalla 360 Advance Gel, 150 ml

€24.40

0 products in total

RELATED PRODUCTS

-5%

somatoline

Somatoline Cosmetic 7 Night Reducer 400 ml

Sesderma Celulex Anti-Cellulite Gel 200 ml

Thiomucase Rebel Areas Anti-Cellulite Stick, 75 ml

SOMATOLINE COSMETIC Express tummy and hips slimming treatment

Redugras Aquaslim Anti-Cellulite and Drainage 10 vials to dilute

Elancyl Slim Design Night 200 ml

Thiomucase Night Reducer Anti-Cellulite Cream, 500 ml

Elancyl Slim Design Slimming Slimming Tightening Slimming Slimming Slimming Slimming Slim Design 150 ml

Thiomucase Fat Reducer Anti-Cellulite Cream, 200 ml

Elancyl My Coach Anti-Cellulite 200 ml

€31.40

€37.09

INFO AND TECHNICAL SPECIFICATIONS

This body care treatment provides 48 hours of hydration1 and corrects: - IMPERFECTION - POST-ACNE SPOTS This light body lotion, developed for acne-prone skin, improves blemishes and post-acne spots in 2 weeks, with a powerful combination of Salicylic Acid and patented Thiamidol. 1 measurement in 27 patients 48 hours after a single application compared to the start of the treatment.